An interventional study of Benefits to Child and Benefits to Society in Parental Vaccine Intentions for Their Children, sponsored by Indiana University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-12-19.
Sponsored by Indiana University · Not applicable, Interventional, and Health services research
The purpose of this study is to examine the impact of different message framing (i.e., communication strategies) on parents' intentions to vaccinate their infants for measles, mumps, and rubella. We hypothesize that information specifically emphasizing various benefits of MMR vaccination will have different impacts on parents' reported levels of intention.
The purpose of this study is to investigate attitudes concerning the Measles, Mumps, \& Rubella (MMR) vaccine among adult parents in the United States. Attitudes will be assessed via a web-based survey administered by Survey Sampling International (SSI). Project sample size is 1,000, all to be recruited by SSI. The survey will take no more than 20-30 minutes to complete. The survey questions and response options attached. With the exception of demographic questions (e.g., age, sex, race) at the end of the survey, questions will not be able to be "skipped" because 1) the survey questions primarily assess attitudes and beliefs, 2) the questions are not of a sensitive nature, 3) responses are anonymous, 4) respondents have indicated their desire and willingness to respond to surveys like this by virtue of their enrollment as an SSI panel member, 5) there is no pressure for respondents to complete the survey, 6) respondents may cease responding to the survey at any time after they begin.
Respondents will be asked to provide information about their children's ages and sex, as well as historical recall information about their past vaccine decisions for their child/children. All respondents will receive general information from the Centers for Disease Control and Prevention (CDC) regarding MMR and the MMR vaccine (taken from the CDC's Vaccine Information Sheet), followed by summarized information about MMR and the MMR vaccine. A quarter of respondents will receive only this information. The other three-quarters of respondents will also receive additional "benefit" information that either underscores: a) the MMR vaccine's benefit to the child who receives it, b) the MMR vaccine's benefits to society as a whole, or c) the MMR vaccine's benefit to both the child who receives it as well as to society as a whole. The purpose of this additional "benefit" information (which will randomly vary among respondents) is to compare people's attitudes when they're given this information about the MMR vaccine's benefit to people's attitudes when they receive the general information. This information is noted in the attached survey, and mimics the information that parents are typically given in clinic settings regarding MMR and the MMR vaccine. The purpose of this study is to systematically assess people's responses to this information, which is already offered in clinical settings and is publicly available via the CDC.
Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.
Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
CDC VIS + message emphasizing benefits of MMR vaccine to child
Behavioral: Benefits to Child · Behavioral: CDC VIS
CDC Vaccine Information Statement (VIS)
Behavioral: CDC VIS
CDC VIS + message emphasizing benefits of MMR vaccine to society
Behavioral: Benefits to Society · Behavioral: CDC VIS
CDC VIS + message emphasizing benefits of MMR vaccine to both child and to society
Behavioral: Benefits to Child and Society · Behavioral: CDC VIS
CDC VIS + message emphasizing benefits to child of MMR vaccine
CDC VIS + message emphasizing benefits to society of MMR vaccine
CDC VIS + message emphasizing benefits both to child and to society of MMR vaccine
CDC Vaccine Information Statement (VIS)
Parental MMR Vaccine Intentions for Their Children
Participants report their willingness to vaccinate their infant for measles, mumps, and rubella on an 11-point scale anchored at 0(not at all likely) and 100(extremely likely) per the following prompt: On the scale below, please indicate how likely you are to have your baby receive the MMR vaccine.
Time frame: Outcome (MMR intention) is measured immediately after participant receives message; measurement is immediate (not longitudnal follow-up)
No study locations are listed for this record.
This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Indiana University